| When translational neuroscience fails in the clinic: Dexamethasone prior to virtual reality exposure therapy increases drop-out rates JL Maples-Keller, T Jovanovic, BW Dunlop, S Rauch, C Yasinski, ... Journal of anxiety disorders 61, 89-97, 2019 | 49 | 2019 |
| A randomized controlled trial of 3, 4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults JL Maples-Keller, SD Norrholm, M Burton, C Reiff, C Coghlan, ... Journal of Psychopharmacology 36 (3), 368-377, 2022 | 31 | 2022 |
| Acquisition, extinction, and return of fear in veterans in intensive outpatient prolonged exposure therapy: A fear-potentiated startle study J Maples-Keller, LE Watkins, KM Nylocks, C Yasinski, C Coghlan, K Black, ... Behaviour research and therapy 154, 104124, 2022 | 22 | 2022 |
| Treatment of antagonism: Cognitive behavioral therapy JL Maples-Keller, C Yasinski, C Coghlan, A Powers The handbook of antagonism, 351-364, 2019 | 7 | 2019 |
| Perceptions of psychedelic-assisted therapy among Black Americans S Carter, G Packard, C Coghlan, JR George, AJ Brown, THW Ching, ... Journal of Mood & Anxiety Disorders 4, 100023, 2023 | 3 | 2023 |
| MDMA's Impact on Fear Extinction and Subjective and Observer Rated Effects in Healthy Adults J Maples-Keller, S Norrholm, M Burton, C Reiff, C Coghlan, T Jovanovic, ... NEUROPSYCHOPHARMACOLOGY 48, 79-80, 2023 | | 2023 |
